Profile
Laurie Hastings is Senior Vice President-Human Resources at Vaxart, Inc. since 2024.
Formerly, Ms. Hastings was Vice President-People & Culture at Encoded Therapeutics, Inc. from 2022 to 2023 and Vice President-Human Resources at Relypsa, Inc. from 2016 to 2021.
Ms. Hastings completed undergraduate education at Arizona State University.
Laurie Hastings active positions
| Companies | Position | Start |
|---|---|---|
| VAXART, INC. | Human Resources Officer | 01/04/2024 |
Former positions of Laurie Hastings
| Companies | Position | End |
|---|---|---|
Encoded Therapeutics, Inc.
Encoded Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Encoded Therapeutics, Inc. operates as a biotechnology company that engages in the development of precision medicines and therapy for genetic disorders. It focuses on viral gene therapies. The company was founded by Kartik Ramamoorthi and Stephanie Tagliatela and is headquartered in South San Francisco, CA. | Human Resources Officer | 01/01/2023 |
| RELYPSA INC | Human Resources Officer | 01/02/2021 |
Training of Laurie Hastings
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
Arizona State University
Arizona State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Relypsa, Inc.
Relypsa, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops non-absorbed polymeric drugs for applications in cardiovascular and renal diseases | Health Technology |
Vaxart, Inc.
Vaxart, Inc. BiotechnologyHealth Technology Develops vaccines | Health Technology |
Encoded Therapeutics, Inc.
Encoded Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Encoded Therapeutics, Inc. operates as a biotechnology company that engages in the development of precision medicines and therapy for genetic disorders. It focuses on viral gene therapies. The company was founded by Kartik Ramamoorthi and Stephanie Tagliatela and is headquartered in South San Francisco, CA. | Commercial Services |
- Stock Market
- Insiders
- Laurie Hastings
















